Patients with lower levels of DOK7 had worse overall survival (OS) (P < 0.001) in 626 breast cancer patients (314 samples in low levels of DOK7 and 312 samples in high levels of DOK7) (Figure 2(a)). Here, DOK7 is linked to breast cancer.